Disarm Therapeutics is a biotechnology company that creates disease-modifying therapeutics for patients with axonal degeneration. Its drugs prevent the loss of axons and treat neurological diseases including multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies that enable patients to avail treatment for acute diseases of the central, ocular, and peripheral nervous systems. Disarm Therapeutics was founded in 2016 and is headquartered in Cambridge, Massachusetts.

Develops and manufactures drugs related to immunology, neurobiology and oncology

Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda holds an exclusive agreement with the Weizmann Institute to commercialize the unique intellectual property developed by the scientists. The income generated serves to support further basic research and science education. - Identify and assess research projects with commercial potential. - Protect the intellectual property of the Institute and its scientists. - Create business relationships and license the Institute’s inventions and technologies to the industry. - Channel funding from industry to research projects. For further information please contact Tamir Huberman, CIO and Head of Marketing

Accure Therapeutics SL is a company headquartered in Barcelona, Spain. The firm develops medicines to treat patient suffering from central nervous system. It was founded in 2020 by Laurent Nguyen, who has been the CEO since that date.

Founded in 2007, Helis is a micro motor automation equipment solution provider in China. The industrial park covers an area of 10,000 square meters, with more than 200 employees and more than 80 medium and senior engineers. Among them, 40% have 10-20 years of motor industry research and development experience and more than 400 national patent certificates. The company has precision CNC 43 sets, EDM machines, CNC lathes, and other electromechanical processing equipment, 5000 square meters of modern assembly workshop, and can assemble 20 fully automatic lines at the same time. The company integrates R&D, production, sales and service, and is committed to providing automation solutions for DC brushless and brushless motors. Its main products include full automatic motor whole line, winding machine, rotor, stator, end cover and other series of automation equipment. We have established strategic cooperation relationships with well-known enterprises such as Dechang Electric, Marlboro Motor, BYD, Valeo, Nissan, Foxconn, Dianzhuang, Midea, Elita, Del Auto, etc. The products are exported to Europe, South America, Southeast Asia and other countries and regions, as well as all parts of China

Cornell provides education about the earth and atmospheric sciences. They offer summer and winter sessions. Their students contact them through phone and email services.

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics. Its selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a genetic medicines technology that enables precise delivery to target organs and cells beyond the liver.

Oligomerix, Inc. develops novel therapeutics and diagnostic assays for alzheimer diseases. It is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors, immunotherapeutic approaches and biomarkers targeting tau oligomers. The firm's platform is based on small neurotoxic aggregates of proteins such as tau oligomers, an important target for AD and other tauopathies characterized by the progressive accumulation of tau aggregates. The company was founded by James G. Moe, Eliot J. Davidowitz, Ishita Chatterjee and Pedro M. Rojas in 2006 and is headquartered in New York, NY.

The Rural Development Administration (Korean: 농촌진흥청; Hanja: 農村振興廳, RDA) is one of an agriculture organizations in South Korea and is run under the Ministry of Agriculture, Food and Rural Affairs. The headquarters are in Wansan-gu, Jeonju.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom.

FUJIFILM Corp. engages in the provision of imaging and information solutions. Its offers photography equipment, supplies and services, optical devices, healthcare, high-performance materials, graphic systems, recording media, and industrial products. The company was founded on October 2, 2006 and is headquartered in Tokyo, Japan.

Toray Industries, Inc. (東レ株式会社 Tōre Kabushiki-gaisha) is a multinational corporation headquartered in Japan that specializes in industrial products centered on technologies in organic synthetic chemistry, polymer chemistry, and biochemistry.

Neuraptive Therapeutics is a medical technology company that brings novel products to patients with peripheral nerve injuries. Neuraptive was founded to commercialize innovative technology from the University of Texas. Its franchise therapeutics product is designed for administration during surgery to improve outcomes for patients impacted by acute nerve injury repairs and reconstructive surgical procedures involving peripheral nerves. Founded in 2016, Neuraptive Therapeutics is headquartered in Lafayette, Colorado.

NDI Medical, founded in 2002, is a medical device incubator. They develop high-growth companies that focus on innovative neurostimulation technologies to address significant unmet health conditions. Their team includes seasoned entrepreneurs, scientists, physician advisors, and professionals in clinical and regulatory affairs, product development, quality, and finance.

Neuralink develops a brain-machine interface that provides solutions for those with paralysis. Neuralink engages in the development of high-bandwidth brain-machine interfaces. It is driven to build devices that will help people with paralysis and invent new technologies that will expand their abilities and community.